Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Can Technology Improve Adherence to Long-Term Therapies?</title><author><name sortKey="Reach, Gerard" sort="Reach, Gerard" uniqKey="Reach G" first="Gérard" last="Reach">Gérard Reach</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20144287</idno><idno type="pmc">2769863</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769863</idno><idno type="RBID">PMC:2769863</idno><date when="2009">2009</date><idno type="wicri:Area/Pmc/Corpus">000247</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000247</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Can Technology Improve Adherence to Long-Term Therapies?</title><author><name sortKey="Reach, Gerard" sort="Reach, Gerard" uniqKey="Reach G" first="Gérard" last="Reach">Gérard Reach</name></author></analytic><series><title level="j">Journal of diabetes science and technology (Online)</title><idno type="eISSN">1932-2968</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Therapeutic nonadherence is defined as the lack of equivalence between the behavior of the patients and their prescribed medical treatment. Consequences of nonadherence include not only health outcomes, but also cost saving. Thus, this issue gets paramount importance in contemporary medicine.</p></sec><sec sec-type="methods"><title>Method</title><p>The aim of this article is to discuss the relationships between technology and adherence by asking the following three questions. (1) How can technology be used to monitor patient adherence? (2) Considering the mechanisms of nonadherence in chronic diseases, is there room for technology in interventions aimed to improve patient adherence? (3) What about adherence to technology in diabetes care?</p></sec><sec><title>Results and Conclusion</title><p>Technology may help improve adherence to long-term therapies by (1) giving a concrete representation of adherence rewards, (2) overcoming immediate obstacles to adherence, such as the fear of hypoglycemia, and (3) providing an opportunity for patient–doctor <italic>conversations</italic>. This assumes, however, that both the patient and the doctor are convinced that technologies are useful.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Sci Technol</journal-id><journal-id journal-id-type="publisher-id">dst</journal-id><journal-title-group><journal-title>Journal of diabetes science and technology (Online)</journal-title></journal-title-group><issn pub-type="epub">1932-2968</issn><publisher><publisher-name>Diabetes Technology Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20144287</article-id><article-id pub-id-type="pmc">2769863</article-id><article-id pub-id-type="publisher-id">dst.3.3.0492</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Can Technology Improve Adherence to Long-Term Therapies?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Reach</surname><given-names>Gérard</given-names></name><degrees>M.D., FRCP (Edin)</degrees><aff><institution>Department of Endocrinology, Diabetes and Metabolic Diseases, Avicenne Hospital</institution>,<addr-line>Bobigny, France</addr-line></aff></contrib></contrib-group><author-notes><corresp>Correspondence to: Gérard Reach, M.D., FRCP, Department of Endocrinology, Diabetes and Metabolic Diseases, Avicenne Hospital APHP and EA 3412, CRNH-IdF, Paris 13 University, Bobigny, France; email address <email>gerard.reach@avc.aphp.fr</email></corresp><fn><p><bold>Disclosure:</bold> Professor Reach has performed experimental and clinical studies evaluating a glucose sensor currently in development by I-Sense, Portland, Oregon. He has served on the scientific advisory boards of Abbott, Bayer Diagnostics, Cygnus, LifeScan, and Pendragon. In addition, he has been an invited guest lecturer in symposia sponsored by Abbott, Bayer Diagnostics, GSK, LifeScan, Novo-Nordisk, Sanofi-Aventis, and Takeda.</p></fn></author-notes><pub-date pub-type="epub"><month>5</month><year>2009</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2009</year></pub-date><volume>3</volume><issue>3</issue><fpage>492</fpage><lpage>499</lpage><permissions><copyright-statement>© 2009 Diabetes Technology Society</copyright-statement></permissions><abstract><sec><title>Background</title><p>Therapeutic nonadherence is defined as the lack of equivalence between the behavior of the patients and their prescribed medical treatment. Consequences of nonadherence include not only health outcomes, but also cost saving. Thus, this issue gets paramount importance in contemporary medicine.</p></sec><sec sec-type="methods"><title>Method</title><p>The aim of this article is to discuss the relationships between technology and adherence by asking the following three questions. (1) How can technology be used to monitor patient adherence? (2) Considering the mechanisms of nonadherence in chronic diseases, is there room for technology in interventions aimed to improve patient adherence? (3) What about adherence to technology in diabetes care?</p></sec><sec><title>Results and Conclusion</title><p>Technology may help improve adherence to long-term therapies by (1) giving a concrete representation of adherence rewards, (2) overcoming immediate obstacles to adherence, such as the fear of hypoglycemia, and (3) providing an opportunity for patient–doctor <italic>conversations</italic>. This assumes, however, that both the patient and the doctor are convinced that technologies are useful.</p></sec></abstract><kwd-group><kwd>adherence</kwd><kwd>artificial pancreas</kwd><kwd>conversation</kwd><kwd>electronic reminders</kwd><kwd>hypoglycemia</kwd><kwd>memory</kwd><kwd>medication event monitoring systems</kwd><kwd>mental states</kwd><kwd>technology</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000247 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000247 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= TherFamFrancoV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.29. |  |